Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Repligen Corp shares valued at $44,275 were sold by DAWES KAREN A on Dec 17 ’25. At $161.00 per share, DAWES KAREN A sold 275 shares. The insider’s holdings dropped to 91,821 shares worth approximately $14.88 million following the completion of this transaction.
Also, DAWES KAREN A purchased 275 shares, netting a total of over 44,275 in proceeds.
Before that, Loeillot Olivier had sold 7,041 shares from its account. In a trade valued at $1,196,970, the Chief Executive Officer traded Repligen Corp shares for $170.00 each. Upon closing the transaction, the insider’s holdings decreased to 7,041 shares, worth approximately $5.82 million.
As published in their initiating research note from HSBC Securities on October 01, 2025, Repligen Corp [RGEN] has been a Buy and the price target has been revised to $150. Analysts at Evercore ISI upgraded the stock from ‘”an In-line”‘ to ‘”an Outperform”‘ outlook in a report released in late September. Earlier on June 24, 2025, Barclays initiated its rating. Their recommendation was “an Overweight” for RGEN stock.
Analyzing RGEN Stock Performance
On last trading session, Repligen Corp [NASDAQ: RGEN] plunged -3.16% to $162.03. The stock’s lowest price that day was $158.91, but it reached a high of $168.25 in the same session. During the last five days, there has been a drop of approximately -4.15%. Over the course of the year, Repligen Corp shares have jumped approximately 2.27%.
Is Repligen Corp subject to short interest?
Stocks of Repligen Corp saw a sharp steep in short interest on 2025-12-31 dropping by -0.38 million shares to 3.93 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 4.31 million shares. A decline of -9.57% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.58 of the overall float, the days-to-cover ratio (short ratio) decline to 6.58.
Which companies own the most shares of Repligen Corp (RGEN)?
In terms of Repligen Corp share price expectations, FactSet research, analysts set an average price target of 177.5 in the next 12 months, up nearly 6.09% from the previous closing price of $167.31. Analysts anticipate Repligen Corp stock to reach 205 by 2026, with the lowest price target being 150. In spite of this, 9 analysts ranked Repligen Corp stock as Buy at the end of 2026. On April 29, 2025, Wolfe Research assigned a price target of “an Outperform” to the stock and upgraded coverage with a $160.
